FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pedro Méndez

Research Profile

Disorders

Chemicals & Drugs

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Isabel Bover; Carlos Camps; Imane Chaib; Carlota Costa; Ana Gimenez-Capitan; Eloisa Jantus Lewintre; Pedro Méndez; Miguel Angel Molina-Vila; Jose L Ramirez-Serrano; Christian Rolfo; Sara Simonetti; Rafael Sirera; Miquel Taron; Susana Benlloch; Rafael Rosell
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology Workshop.
Enric Carcereny; Jose Luis Ramirez; Maria Sanchez-Ronco; Dolores Isla; Manuel Cobo; Teresa Moran; Itziar de Aguirre; Tatsuro Okamoto; Jia Wei; Mariano Provencio; Guillermo Lopez-Vivanco; Carlos Camps; Manuel Domine; Vicente Alberola; Jose Miguel Sanchez; Bartomeu Massuti; Pedro Méndez; Miquel Taron; Rafael Rosell
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.
Rafael Rosell; Laia Perez-Roca; Jose Javier Sanchez; Manuel Cobo; Teresa Moran; Imane Chaib; Mariano Provencio; Manuel Domine; Maria Angeles Sala; Ulpiano Jimenez; Pilar Diz; Isidoro Barneto; Jose Antonio Macias; Ramon de las Peñas; Silvia Catot; Dolores Isla; Jose Miguel Sanchez; Rafael Ibeas; Guillermo Lopez-Vivanco; Juana Oramas; Pedro Méndez; Noemi Reguart; Remei Blanco; Miquel Taron
Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pedro Méndez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Isabel Bover; Carlos Camps; Imane Chaib; Carlota Costa; Ana Gimenez-Capitan; Eloisa Jantus Lewintre; Pedro Méndez; Miguel Angel Molina-Vila; Jose L Ramirez-Serrano; Christian Rolfo; Sara Simonetti; Rafael Sirera; Miquel Taron; Susana Benlloch; Rafael Rosell
Fifth Educational Symposium of the Spanish Lung Cancer Group: report on the Molecular Biology Workshop.
Lung cancer (Amsterdam, Netherlands) 2011;74(3):535-43.
2010: Enric Carcereny; Jose Luis Ramirez; Maria Sanchez-Ronco; Dolores Isla; Manuel Cobo; Teresa Moran; Itziar de Aguirre; Tatsuro Okamoto; Jia Wei; Mariano Provencio; Guillermo Lopez-Vivanco; Carlos Camps; Manuel Domine; Vicente Alberola; Jose Miguel Sanchez; Bartomeu Massuti; Pedro Méndez; Miquel Taron; Rafael Rosell
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2010;68(3):491-7.
2009: Rafael Rosell; Laia Perez-Roca; Jose Javier Sanchez; Manuel Cobo; Teresa Moran; Imane Chaib; Mariano Provencio; Manuel Domine; Maria Angeles Sala; Ulpiano Jimenez; Pilar Diz; Isidoro Barneto; Jose Antonio Macias; Ramon de las Peñas; Silvia Catot; Dolores Isla; Jose Miguel Sanchez; Rafael Ibeas; Guillermo Lopez-Vivanco; Juana Oramas; Pedro Méndez; Noemi Reguart; Remei Blanco; Miquel Taron
Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.
PloS one 2009;4(5):e5133.
2009: Roberta Bartolucci; Jia Wei; Jose Javier Sanchez; Laia Perez-Roca; Imane Chaib; Francesco Puma; Raffaele Farabi; Pedro Méndez; Fausto Roila; Tatsuro Okamoto; Miquel Taron; Rafael Rosell
XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
Clinical lung cancer 2009;10(1):47-52.
2008: Marcin Skrzypski; Ewa Jassem; Miquel Taron; Jose Javier Sanchez; Pedro Méndez; Witold Rzyman; Grazyna Gulida; Dan Raz; David Jablons; Mariano Provencio; Bartomeu Massuti; Imane Chaib; Laia Perez-Roca; Jacek Jassem; Rafael Rosell
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4794-9.
2008: John Souglakos; I Boukovinas; M Taron; Pedro Méndez; Dimitris Mavroudis; M Tripaki; Dora Hatzidaki; ANASTASIOS KOUTSOPOULOS; Efstathios N Stathopoulos; Vassilis Georgoulias; R Rosell
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine.
British journal of cancer 2008;98(10):1710-5.
2008: Ioannis Boukovinas; Chara Papadaki; Pedro Méndez; Miquel Taron; Dimitris Mavroudis; ANASTASIOS KOUTSOPOULOS; Maria Sanchez-Ronco; Jose Javier Sanchez; Maria Trypaki; Eustathios Staphopoulos; Vassilis Georgoulias; Rafael Rosell; John Souglakos
Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.
PloS one 2008;3(11):e3695.
2007: Rafael Rosell; Pedro Méndez; Dolores Isla; Miquel Taron
Platinum resistance related to a functional NER pathway.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(12):1063-6.
2007: Joaquim Bellmunt; Luis Paz-Ares; Mauricio Cuello; Fabiana Cecere; Santiago Albiol; Vicente Guillem; E Gallardo; Joan Carles; Pedro Méndez; Juan J de la Cruz; Miquel Taron; Rafael Rosell; José Baselga
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(3):522-8.
2007: Rafael Rosell; Marcin Skrzypski; Ewa Jassem; Miquel Taron; Roberta Bartolucci; Jose Javier Sanchez; Pedro Méndez; Imane Chaib; Laia Perez-Roca; Amelia Szymanowska; Witold Rzyman; Francesco Puma; Grazyna Kobierska-Gulida; Raffaele Farabi; Jacek Jassem
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.
PloS one 2007;2(11):e1129.
2006: Rafael Rosell; Teresa Moran; M Fernanda Salazar; Pedro Méndez; Itziar de Aguirre; José Luis Ramirez; Dolores Isla; Manuel Cobo; Carlos Camps; Guillermo Lopez-Vivanco; Vicente Alberola; Miquel Taron
The place of targeted therapies in the management of non-small cell bronchial carcinoma. Molecular markers as predictors of tumor response and survival in lung cancer.
Revue des maladies respiratoires 2006;23(5 Pt 3):16S131-16S136.
2006: Ramon de las Peñas; Maria Sanchez-Ronco; Vicente Alberola; Miquel Taron; Carlos Camps; R Garcia-Carbonero; Bartomeu Massuti; Cristina Queralt; M Botia; R Garcia-Gomez; Dolores Isla; Manuel Cobo; Mariacarmela Santarpia; Fabiana Cecere; Pedro Méndez; Jose Javier Sanchez; Rafael Rosell
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):668-75.
2005: Rafael Rosell; Yukito Ichinose; Miquel Taron; Carme Sarries; Cristina Queralt; Pedro Méndez; Jose Miguel Sanchez; Ken-Ichi Nishiyama; Teresa Moran; Beatriz Cirauqui; José-Luis Mate; Benjamin Besse; Noemi Reguart; Maria Perez; Jose Javier Sanchez
Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2005;50(1):25-33.
2005: Hernán Cortes-Funes; C Gomez; Rafael Rosell; P Valero; Carlos Garcia-Giron; A Velasco; A Izquierdo; Pilar Diz; Carlos Camps; D Castellanos; Vicente Alberola; Felipe Cardenal; Jose Luis Gonzalez-Larriba; J M Vieitez; I Maeztu; Jose Javier Sanchez; Cristina Queralt; C Mayo; Pedro Méndez; T Moran; Miquel Taron
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1081-6.
2005: Enriqueta Felip; Miquel Taron; Rafael Rosell; Pedro Méndez; Cristina Queralt; Maria Sanchez Ronco; Jose Javier Sanchez; Jose Miguel Sanchez; Jose Maestre; Joaquim Majo
Clinical significance of hypoxia-inducible factor-1a messenger RNA expression in locally advanced non-small-cell lung cancer after platinum agent and gemcitabine chemotherapy followed by surgery.
Clinical lung cancer 2005;6(5):299-303.
2004: Miquel Taron; Rafael Rosell; Enriqueta Felip; Pedro Méndez; John Souglakos; Maria Sanchez Ronco; Cristina Queralt; Joaquim Majo; Jose Miguel Sanchez; Jose Javier Sanchez; Jose Maestre
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer.
Human molecular genetics 2004;13(20):2443-9.
2004: Rafael Rosell; Enriqueta Felip; Miquel Taron; Joaquim Majo; Pedro Méndez; Maria Sanchez-Ronco; Cristina Queralt; Jose Javier Sanchez; Jose Maestre
Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 2):4215s-4219s.
2003: Carmen Balaña; José Luis Ramirez; Miquel Taron; Yannis Roussos; Aurelio Ariza; Rosa Ballester; Carme Sarries; Pedro Méndez; Jose Javier Sanchez; Rafael Rosell
O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1461-8.
2003: José Luis Ramirez; Miquel Taron; Carmen Balaña; Carme Sarries; Pedro Méndez; Itziar de Aguirre; Luis Nuñez; Barbara Roig; Cristina Queralt; M Botia; Rafael Rosell
Serum DNA as a tool for cancer patient management.
Roczniki Akademii Medycznej w Białymstoku (1995) 2003;48():34-41.